FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:874-881 March 29, 1990 Number 13 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

An association between the ingestion tryptophan and a syndrome characterized by scleroderma-like skin abnormalities, fasciitis, and eosinophilia has recently been recognized in the United States. We report the clinical and histopathological findings in nine patients and the results of biochemical analyses of tryptophan metabolism in seven patients with this syndrome. Edema of the extremities, frequently accompanied by pruritus, paresthesia, and myalgia, developed in the nine patients (six women and three men; age range, 30 to 66 years) 1 to 18 months after the start of therapy with tryptophan (1.5 to 3.0 g daily) for insomnia, depression, or obesity. Five patients were taking drugs (benzodiazepines) known to inhibit hypothalamic-pituitary-adrenal function, and one had adrenal insufficiency. All had blood eosinophilia in the acute phase of their illness (mean eosinophil count [+/- SD], 3.62 +/- 2.87 X 10(9) cells per liter). All had histopathological changes in the dermis and subcutaneous tissue typical of scleroderma, and seven patients had eosinophils. The fascia was inflamed and fibrotic, and adjacent skeletal muscle often showed perifascicular inflammation. Tryptophan was discontinued in all patients, and eight received prednisone. The cutaneous symptoms improved, but only two patients had complete resolution of their illness. The patients had plasma levels of tryptophan before and after an oral dose of tryptophan that were similar to those in normal subjects. Plasma levels of L-kynurenine and quinolinic acid, which are metabolites of tryptophan, were significantly higher in four patients with active disease than in three patients studied after eosinophilia had resolved or in five normal subjects (P less than 0.001)--findings consistent with the activation of the enzyme indoleamine-2,3-dioxygenase. This illness resembles eosinophilic fasciitis and probably represents one aspect of the recently reported eosinophilia-myalgia syndrome. The development of the syndrome may result from a confluence of several factors, including the ingestion of tryptophan, exposure to agents that activate indoleamine-2,3-dioxygenase, and possibly, impaired function of the hypothalamic-pituitary-adrenal axis.

Source Information

Department of Medicine, Medical University of South Carolina, Charleston.

This article has been cited by other articles:

• MORA, G. F. (2009). Systemic Sclerosis: Environmental Factors. The Journal of Rheumatology 36: 2383-2396 [Abstract] [Full Text]  
• Walker, U A, Tyndall, A, Czirjak, L, Denton, C P, Farge-Bancel, D, Kowal-Bielecka, O, Muller-Ladner, U, Matucci-Cerinic, M, and the EUSTAR co-authors, (2009). Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 68: 856-862 [Abstract] [Full Text]  
• Jeong, Y. J., Kim, K.-I., Seo, I. J., Lee, C. H., Lee, K. N., Kim, K. N., Kim, J. S., Kwon, W. J. (2007). Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 27: 617-637 [Abstract] [Full Text]  
• Stahl, J. L., Cook, E. B., Pariza, M. A., Cook, M. E., Graziano, F. M. (2001). Effect of L-Tryptophan Supplementation on Eosinophils and Eotaxin in Guinea Pigs. Exp. Biol. Med. 226: 177-184 [Abstract] [Full Text]  
• Killen, J W W, Swift, G L, White, R J (2000). Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad. Med. J. 76: 36-37 [Abstract] [Full Text]  
• Landzberg, M. J., Roberts, D. J., Mark, E. J. (1999). Case 4-1999- A 38-Year-Old Woman with Increasing Pulmonary Hypertension after Delivery. NEJM 340: 455-464 [Full Text]  
• Fishman, A. P. (1999). Aminorex to Fen/Phen : An Epidemic Foretold. Circulation 99: 156-161 [Full Text]  
• Armstrong, C., Lewis, T., D'Esposito, M., Freundlich, B. (1997). Eosinophilia-myalgia syndrome: selective cognitive impairment, longitudinal effects, and neuroimaging findings. J. Neurol. Neurosurg. Psychiatry 63: 633-641 [Abstract] [Full Text]  
• Varga, J., Jimenez, S. A. (1994). Chemical Exposure-Induced Cutaneous Fibrosis: Lessons From 'Experiments of Nature'. Arch Dermatol 130: 97-100 [Abstract]  
• Hatch, D. L., Goldman, L. R. (1993). Reduced Severity of Eosinophilia-Myalgia Syndrome Associated With the Consumption of Vitamin-Containing Supplements Before Illness. Arch Intern Med 153: 2368-2373 [Abstract]  
• Sternberg, E. M., Chrousos, G. P., Wilder, R. L., Gold, P. W. (1992). The Stress Response and the Regulation of Inflammatory Disease. ANN INTERN MED 117: 854-866 [Abstract]  
• Lynn, J., Rammohan, K. W., Bornstein, R. A., Kissel, J. T. (1992). Central Nervous System Involvement in the Eosinophilia-Myalgia Syndrome. Arch Neurol 49: 1082-1085 [Abstract]  
• Hauser, S. L., Doolittle, T. H., Lopez-Bresnahan, M., Shahani, B., Schoenfeld, D., Shih, V. E., Growdon, J., Lehrich, J. R. (1992). An Antispasticity Effect of Threonine in Multiple Sclerosis. Arch Neurol 49: 923-926 [Abstract]  
• Hedberg, K., Urbach, D., Slutsker, L., Matson, P., Fleming, D. (1992). Eosinophilia-Myalgia Syndrome: Natural History in a Population-Based Cohort. Arch Intern Med 152: 1889-1892 [Abstract]  
• Hertzman, P. A., Maddoux, G. L., Sternberg, E. M., Heyes, M. P., Mefford, I. N., Kephart, G. M., Gleich, G. J. (1992). Repeated Coronary Artery Spasm in a Young Woman With the Eosinophilia-Myalgia Syndrome. JAMA 267: 2932-2934 [Abstract]  
• Varga, J., Uitto, J., Jimenez, S. A. (1992). The Cause and Pathogenesis of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 116: 140-147 [Abstract]  
• Kamb, M. L., Murphy, J. J., Jones, J. L., Caston, J. C., Nederlof, K., Horney, L. F., Swygert, L. A., Falk, H., Kilbourne, E. M. (1992). Eosinophilia-Myalgia Syndrome in L-Tryptophan--Exposed Patients. JAMA 267: 77-82 [Abstract]  
• Lacour, J. P., Perrin, C., Bodokh, I., Ortonne, J. P. (1991). Severe Sclerodermalike Manifestations of the Eosinophilia-Myalgia Syndrome Despite Concomitant Colchicine Therapy. Arch Dermatol 127: 1732-1733 [Abstract]  
• Culpepper, R. C., Williams, R. G., Mease, P. J., Koepsell, T. D., Kobayashi, J. M. (1991). Natural History of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 115: 437-442 [Abstract]  
• Blauvelt, A., Falanga, V. (1991). Idiopathic and L-Tryptophan-Associated Eosinophilic Fasciitis Before and After L-Tryptophan Contamination. Arch Dermatol 127: 1159-1166 [Abstract]  
• Silver, R. M. (1991). Unraveling the Eosinophilia-Myalgia Syndrome. Arch Dermatol 127: 1214-1216 [Abstract]  
• James, T. N., Kamb, M. L., Sandberg, G. A., Silver, R. M., Kilbourne, E. M. (1991). Postmortem Studies of the Heart in Three Fatal Cases of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 115: 102-110 [Abstract]  
• Chan, L. S., Hanson, C. A., Cooper, K. D. (1991). Concurrent Eosinophilic Fasciitis and Cutaneous T-Cell Lymphoma: Eosinophilic Fasciitis as a Paraneoplastic Syndrome of T-Cell Malignant Neoplasms?. Arch Dermatol 127: 862-865 [Abstract]  
• Tolander, L. M., Bamford, C. R., Yoshino, M. T., Downing, S., Bryan, G. (1991). Neurologic Complications of the Tryptophan-Associated Eosinophilia-Myalgia Syndrome. Arch Neurol 48: 436-438 [Abstract]  
• Philen, R. M., Eidson, M., Kilbourne, E. M., Sewell, C. M., Voorhees, R. (1991). Eosinophilia-Myalgia Syndrome: A Clinical Case Series of 21 Patients. Arch Intern Med 151: 533-537 [Abstract]  
• Lindgren, C.E., Walker, L. A., Bolton, P. (1991). L-tryptophan Induced Eosinophilia-Myalgia Syndrome. The Journal of the Royal Society for the Promotion of Health 111: 29-30  
• Gordon, M. L., Lebwohl, M. G., Phelps, R. G., Cohen, S. R., Fleischmajer, R. (1991). Eosinophilic Fasciitis Associated With Tryptophan Ingestion: A Manifestation of Eosinophilia-Myalgia Syndrome. Arch Dermatol 127: 217-220 [Abstract]  
• Greenbaum, S. S., Varga, J. (1991). Corticosteroid-Induced Juxta-articular Adiposis Dolorosa. Arch Dermatol 127: 231-233 [Abstract]  
• LEWKONIA, R. M. (1990). Myalgia and Eosinophilia Associated With Ingestion of Tryptophan: An Intriguing New Syndrome. Arch Intern Med 150: 2005-2007 [Abstract]  
• Slutsker, L., Hoesly, F. C., Miller, L., Williams, L. P., Watson, J. C., Fleming, D. W. (1990). Eosinophilia-Myalgia Syndrome Associated With Exposure to Tryptophan From a Single Manufacturer. JAMA 264: 213-217 [Abstract]  
• (1990). TRYPTOPHAN AND EOSINOPHILIA-MYALGIA SYNDROME: CLINICAL UPDATE. JWatch General 1990: 2-2 [Full Text]